1
|
Alzghool OM, Aarnio R, Helin JS, Wahlroos S, Keller T, Matilainen M, Solis J, Danon JJ, Kassiou M, Snellman A, Solin O, Rinne JO, Haaparanta-Solin M. Correction: Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [ 11C]SMW139 and [ 18F]F-DPA. EJNMMI Res 2024; 14:44. [PMID: 38700617 PMCID: PMC11068707 DOI: 10.1186/s13550-024-01103-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/07/2024] Open
Affiliation(s)
- Obada M Alzghool
- PET Preclinical Imaging Laboratory, Turku PET Centre, University of Turku, Tykistökatu 6 A, Turku, 20520, Finland
- Medicity Research Laboratory, University of Turku, Tykistökatu 6 A, Turku, 20520, Finland
- Drug Research Doctoral Programme, University of Turku, Turku, Finland
- Turku University Hospital, Turku PET Centre, Kiinamyllynkatu 4-8, 20520, Turku, Finland
| | - Richard Aarnio
- PET Preclinical Imaging Laboratory, Turku PET Centre, University of Turku, Tykistökatu 6 A, Turku, 20520, Finland
- Medicity Research Laboratory, University of Turku, Tykistökatu 6 A, Turku, 20520, Finland
- Drug Research Doctoral Programme, University of Turku, Turku, Finland
| | - Jatta S Helin
- PET Preclinical Imaging Laboratory, Turku PET Centre, University of Turku, Tykistökatu 6 A, Turku, 20520, Finland
- Medicity Research Laboratory, University of Turku, Tykistökatu 6 A, Turku, 20520, Finland
| | - Saara Wahlroos
- Radiopharmaceutical Chemistry Laboratory, Turku PET Centre, University of Turku, Kiinamyllynkatu 4-8, FI-20520, Turku, Finland
| | - Thomas Keller
- Radiopharmaceutical Chemistry Laboratory, Turku PET Centre, University of Turku, Kiinamyllynkatu 4-8, FI-20520, Turku, Finland
| | - Markus Matilainen
- Turku University Hospital, Turku PET Centre, Kiinamyllynkatu 4-8, 20520, Turku, Finland
| | - Junel Solis
- Turku BioImaging, Åbo Akademi University and University of Turku, Turku, Finland
| | - Jonathan J Danon
- School of Chemistry, The University of Sydney, Sydney, NSW, 2006, Australia
| | - Michael Kassiou
- School of Chemistry, The University of Sydney, Sydney, NSW, 2006, Australia
| | - Anniina Snellman
- PET Preclinical Imaging Laboratory, Turku PET Centre, University of Turku, Tykistökatu 6 A, Turku, 20520, Finland
| | - Olof Solin
- Radiopharmaceutical Chemistry Laboratory, Turku PET Centre, University of Turku, Kiinamyllynkatu 4-8, FI-20520, Turku, Finland
- Department of Chemistry, University of Turku, Henrikinkatu 2, Turku, 20500, Finland
- Accelerator Laboratory, Turku PET Centre, Åbo Akademi University, Kiinamyllynkatu, Turku, 4‑8, 20520, Finland
| | - Juha O Rinne
- Turku University Hospital, Turku PET Centre, Kiinamyllynkatu 4-8, 20520, Turku, Finland
- Department of Neurology, Turku University Hospital, Kiinamyllynkatu 4-8, 20520, Turku, Finland
| | - Merja Haaparanta-Solin
- PET Preclinical Imaging Laboratory, Turku PET Centre, University of Turku, Tykistökatu 6 A, Turku, 20520, Finland
- Medicity Research Laboratory, University of Turku, Tykistökatu 6 A, Turku, 20520, Finland
| |
Collapse
|
2
|
Alzghool OM, Aarnio R, Helin JS, Wahlroos S, Keller T, Matilainen M, Solis J, Danon JJ, Kassiou M, Snellman A, Solin O, Rinne JO, Haaparanta-Solin M. Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [ 11C]SMW139 and [ 18F]F-DPA. EJNMMI Res 2024; 14:25. [PMID: 38446249 PMCID: PMC10917722 DOI: 10.1186/s13550-024-01085-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2023] [Accepted: 02/22/2024] [Indexed: 03/07/2024] Open
Abstract
BACKGROUND P2X7 receptor has emerged as a potentially superior PET imaging marker to TSPO, the gold standard for imaging glial reactivity. [11C]SMW139 is the most recently developed radiotracer to image P2X7 receptor. The aim of this study was to image reactive glia in the APP/PS1-21 transgenic (TG) mouse model of Aβ deposition longitudinally using [11C]SMW139 targeting P2X7 receptor and to compare tracer uptake to that of [18F]F-DPA targeting TSPO at the final imaging time point. TG and wild type (WT) mice underwent longitudinal in vivo PET imaging using [11C]SMW139 at 5, 8, 11, and 14 months, followed by [18F]F-DPA PET scan only at 14 months. In vivo imaging results were verified by ex vivo brain autoradiography, immunohistochemical staining, and analysis of [11C]SMW139 unmetabolized fraction in TG and WT mice. RESULTS Longitudinal change in [11C]SMW139 standardized uptake values (SUVs) showed no statistically significant increase in the neocortex and hippocampus of TG or WT mice, which was consistent with findings from ex vivo brain autoradiography. Significantly higher [18F]F-DPA SUVs were observed in brain regions of TG compared to WT mice. Quantified P2X7-positive staining in the cortex and thalamus of TG mice showed a minor increase in receptor expression with ageing, while TSPO-positive staining in the same regions showed a more robust increase in expression in TG mice as they aged. [11C]SMW139 was rapidly metabolized in mice, with 33% of unmetabolized fraction in plasma and 29% in brain homogenates 30 min after injection. CONCLUSIONS [11C]SMW139, which has a lower affinity for the rodent P2X7 receptor than the human version of the receptor, was unable to image the low expression of P2X7 receptor in the APP/PS1-21 mouse model. Additionally, the rapid metabolism of [11C]SMW139 in mice and the presence of several brain-penetrating radiometabolites significantly impacted the analysis of in vivo PET signal of the tracer. Finally, [18F]F-DPA targeting TSPO was more suitable for imaging reactive glia and neuroinflammatory processes in the APP/PS1-21 mouse model, based on the findings presented in this study and previous studies with this mouse model.
Collapse
Affiliation(s)
- Obada M Alzghool
- PET Preclinical Imaging Laboratory, Turku PET Centre, University of Turku, Tykistökatu 6 A, 20520, Turku, Finland.
- Medicity Research Laboratory, University of Turku, Tykistökatu 6 A, 20520, Turku, Finland.
- Drug Research Doctoral Programme, University of Turku, Turku, Finland.
- Turku University Hospital, Turku PET Centre, Kiinamyllynkatu 4-8, 20520, Turku, Finland.
| | - Richard Aarnio
- PET Preclinical Imaging Laboratory, Turku PET Centre, University of Turku, Tykistökatu 6 A, 20520, Turku, Finland
- Medicity Research Laboratory, University of Turku, Tykistökatu 6 A, 20520, Turku, Finland
- Drug Research Doctoral Programme, University of Turku, Turku, Finland
| | - Jatta S Helin
- PET Preclinical Imaging Laboratory, Turku PET Centre, University of Turku, Tykistökatu 6 A, 20520, Turku, Finland
- Medicity Research Laboratory, University of Turku, Tykistökatu 6 A, 20520, Turku, Finland
| | - Saara Wahlroos
- Radiopharmaceutical Chemistry Laboratory, Turku PET Centre, University of Turku, Kiinamyllynkatu 4-8, 20520, Turku, Finland
| | - Thomas Keller
- Radiopharmaceutical Chemistry Laboratory, Turku PET Centre, University of Turku, Kiinamyllynkatu 4-8, 20520, Turku, Finland
| | - Markus Matilainen
- Turku University Hospital, Turku PET Centre, Kiinamyllynkatu 4-8, 20520, Turku, Finland
| | - Junel Solis
- Turku BioImaging, Åbo Akademi University and University of Turku, Turku, Finland
| | - Jonathan J Danon
- School of Chemistry, The University of Sydney, Sydney, NSW, 2006, Australia
| | - Michael Kassiou
- School of Chemistry, The University of Sydney, Sydney, NSW, 2006, Australia
| | - Anniina Snellman
- PET Preclinical Imaging Laboratory, Turku PET Centre, University of Turku, Tykistökatu 6 A, 20520, Turku, Finland
| | - Olof Solin
- Radiopharmaceutical Chemistry Laboratory, Turku PET Centre, University of Turku, Kiinamyllynkatu 4-8, 20520, Turku, Finland
- Department of Chemistry, University of Turku, Henrikinkatu 2, 20500, Turku, Finland
- Accelerator Laboratory, Turku PET Centre, Åbo Akademi University, Kiinamyllynkatu 4-8, 20520, Turku, Finland
| | - Juha O Rinne
- Turku University Hospital, Turku PET Centre, Kiinamyllynkatu 4-8, 20520, Turku, Finland
- Department of Neurology, Turku University Hospital, Kiinamyllynkatu 4-8, 20520, Turku, Finland
| | - Merja Haaparanta-Solin
- PET Preclinical Imaging Laboratory, Turku PET Centre, University of Turku, Tykistökatu 6 A, 20520, Turku, Finland
- Medicity Research Laboratory, University of Turku, Tykistökatu 6 A, 20520, Turku, Finland
| |
Collapse
|
3
|
Abstract
The development of late-stage functionalization (LSF) methodologies, particularly C-H functionalization, has revolutionized the field of organic synthesis. Over the past decade, medicinal chemists have begun to implement LSF strategies into their drug discovery programs, allowing for the drug discovery process to become more efficient. Most reported applications of late-stage C-H functionalization of drugs and drug-like molecules have been to rapidly diversify screening libraries to explore structure-activity relationships. However, there has been a growing trend toward the use of LSF methodologies as an efficient tool for improving drug-like molecular properties of promising drug candidates. In this review, we have comprehensively reviewed recent progress in this emerging area. Particular emphasis is placed on case studies where multiple LSF techniques were implemented to generate a library of novel analogues with improved drug-like properties. We have critically analyzed the current scope of LSF strategies to improve drug-like properties and commented on how we believe LSF can transform drug discovery in the future. Overall, we aim to provide a comprehensive survey of LSF techniques as tools for efficiently improving drug-like molecular properties, anticipating its continued uptake in drug discovery programs.
Collapse
Affiliation(s)
| | | | - Jonathan J Danon
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia
| | - Michael Kassiou
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia
| |
Collapse
|
4
|
Montgomery AP, Joyce JM, Danon JJ, Kassiou M. An update on late-stage functionalization in today's drug discovery. Expert Opin Drug Discov 2023; 18:597-613. [PMID: 37114995 DOI: 10.1080/17460441.2023.2205635] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/29/2023]
Abstract
INTRODUCTION Late-stage functionalization (LSF) allows for the introduction of new chemical groups toward the end of a synthetic sequence, which means new molecules can be rapidly accessed without laborious de novo chemical synthesis. Over the last decade, medicinal chemists have begun to implement LSF strategies into their drug discovery programs, affording benefits such as efficient access to diverse libraries to explore structure-activity relationships and the improvement of physicochemical and pharmacokinetic properties. AREAS COVERED An overview of the key advancements in LSF methodology development from 2019 to 2022 and their applicability to drug discovery is provided. In addition, several examples from both academia and industry where LSF methodologies have been applied by medicinal chemists to their drug discovery programs are presented. EXPERT OPINION Utilization of LSF by medicinal chemists is on the rise, both in academia and in industry. The maturation of the LSF field to produce methodologies bearing increased regioselectivity, scope, and functional group tolerance is envisaged to narrow the gap between methodology development and medicinal chemistry research. The authors predict that the sheer versatility of these techniques in facilitating challenging chemical transformations of bioactive molecules will continue to increase the efficiency of the drug discovery process.
Collapse
Affiliation(s)
| | - Jack M Joyce
- School of Chemistry, The University of Sydney, Sydney, Australia
| | - Jonathan J Danon
- School of Chemistry, The University of Sydney, Sydney, Australia
| | - Michael Kassiou
- School of Chemistry, The University of Sydney, Sydney, Australia
| |
Collapse
|
5
|
Cheng HWA, Callis TB, Montgomery AP, Danon JJ, Jorgensen WT, Ke YD, Ittner LM, Werry EL, Kassiou M. Understanding In Vitro Pathways to Drug Discovery for TDP-43 Proteinopathies. Int J Mol Sci 2022; 23:ijms232314769. [PMID: 36499097 PMCID: PMC9738080 DOI: 10.3390/ijms232314769] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2022] [Revised: 11/15/2022] [Accepted: 11/18/2022] [Indexed: 11/29/2022] Open
Abstract
The use of cellular models is a common means to investigate the potency of therapeutics in pre-clinical drug discovery. However, there is currently no consensus on which model most accurately replicates key aspects of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) pathology, such as accumulation of insoluble, cytoplasmic transactive response DNA-binding protein (TDP-43) and the formation of insoluble stress granules. Given this, we characterised two TDP-43 proteinopathy cellular models that were based on different aetiologies of disease. The first was a sodium arsenite-induced chronic oxidative stress model and the second expressed a disease-relevant TDP-43 mutation (TDP-43 M337V). The sodium arsenite model displayed most aspects of TDP-43, stress granule and ubiquitin pathology seen in human ALS/FTD donor tissue, whereas the mutant cell line only modelled some aspects. When these two cellular models were exposed to small molecule chemical probes, different effects were observed across the two models. For example, a previously disclosed sulfonamide compound decreased cytoplasmic TDP-43 and increased soluble levels of stress granule marker TIA-1 in the cellular stress model without impacting these levels in the mutant cell line. This study highlights the challenges of using cellular models in lead development during drug discovery for ALS and FTD and reinforces the need to perform assessments of novel therapeutics across a variety of cell lines and aetiological models.
Collapse
Affiliation(s)
- Hei W. A. Cheng
- School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia
| | - Timothy B. Callis
- School of Chemistry, Faculty of Science, The University of Sydney, Sydney, NSW 2006, Australia
| | - Andrew P. Montgomery
- School of Chemistry, Faculty of Science, The University of Sydney, Sydney, NSW 2006, Australia
| | - Jonathan J. Danon
- School of Chemistry, Faculty of Science, The University of Sydney, Sydney, NSW 2006, Australia
| | - William T. Jorgensen
- School of Chemistry, Faculty of Science, The University of Sydney, Sydney, NSW 2006, Australia
| | - Yazi D. Ke
- Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, 2 Technology Place, Macquarie University, Sydney, NSW 2109, Australia
| | - Lars M. Ittner
- Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, 2 Technology Place, Macquarie University, Sydney, NSW 2109, Australia
| | - Eryn L. Werry
- School of Chemistry, Faculty of Science, The University of Sydney, Sydney, NSW 2006, Australia
- Central Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia
| | - Michael Kassiou
- School of Chemistry, Faculty of Science, The University of Sydney, Sydney, NSW 2006, Australia
- Correspondence:
| |
Collapse
|
6
|
Abstract
The concept of bioisosterism and the implementation of bioisosteric replacement is fundamental to medicinal chemistry. The exploration of bioisosteres is often used to probe key structural features of candidate pharmacophores and enhance pharmacokinetic properties. As the understanding of bioisosterism has evolved, capabilities to undertake more ambitious bioisosteric replacements have emerged. Scaffold hopping is a broadly used term in the literature referring to a variety of different bioisosteric replacement strategies, ranging from simple heterocyclic replacements to topological structural overhauls. In this work, we have highlighted recent applications of scaffold hopping in the central nervous system drug discovery space. While we have highlighted the benefits of using scaffold hopping approaches in central nervous system drug discovery, these are also widely applicable to other medicinal chemistry fields. We also recommend a shift toward the use of more refined and meaningful terminology within the realm of scaffold hopping.
Collapse
Affiliation(s)
- Timothy B Callis
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia
| | - Taylor R Garrett
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia
| | | | - Jonathan J Danon
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia
| | - Michael Kassiou
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia
| |
Collapse
|
7
|
Ma BB, Montgomery AP, Chen B, Kassiou M, Danon JJ. Strategies for targeting the P2Y 12 receptor in the central nervous system. Bioorg Med Chem Lett 2022; 71:128837. [PMID: 35640763 DOI: 10.1016/j.bmcl.2022.128837] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2022] [Revised: 05/10/2022] [Accepted: 05/26/2022] [Indexed: 11/28/2022]
Abstract
The purinergic 2Y type 12 receptor (P2Y12R) is a well-known biological target for anti-thrombotic drugs due to its role in platelet aggregation and blood clotting. While the importance of the P2Y12R in the periphery has been known for decades, much less is known about its expression and roles in the central nervous system (CNS), where it is expressed exclusively on microglia - the first responders to brain insults and neurodegeneration. Several seminal studies have shown that P2Y12 is a robust, translatable biomarker for anti-inflammatory and neuroprotective microglial phenotypes in models of degenerative diseases such as multiple sclerosis and Alzheimer's disease. An enduring problem for studying this receptor in vivo, however, is the lack of selective, high-affinity small molecule ligands that can bypass the blood-brain barrier and accumulate in the CNS. In this Digest, we discuss previous attempts by researchers to target the P2Y12R in the CNS and opine on strategies that may be employed to design and assess the suitability of novel P2Y12 ligands for this purpose going forward.
Collapse
Affiliation(s)
- Ben B Ma
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia
| | | | - Biling Chen
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia
| | - Michael Kassiou
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia
| | - Jonathan J Danon
- School of Chemistry, The University of Sydney, Sydney, NSW 2006, Australia.
| |
Collapse
|
8
|
Leigh DA, Danon JJ, Fielden SDP, Lemonnier JF, Whitehead GFS, Woltering SL. A molecular endless (7 4) knot. Nat Chem 2021; 13:117-122. [PMID: 33318672 DOI: 10.1038/s41557-020-00594-x] [Citation(s) in RCA: 59] [Impact Index Per Article: 19.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2020] [Accepted: 10/23/2020] [Indexed: 01/30/2023]
Abstract
Current strategies for the synthesis of molecular knots focus on twisting, folding and/or threading molecular building blocks. Here we report that Zn(II) or Fe(II) ions can be used to weave ligand strands to form a woven 3 × 3 molecular grid. We found that the process requires tetrafluoroborate anions to template the assembly of the interwoven grid by binding within the square cavities formed between the metal-coordinated criss-crossed ligands. The strand ends of the grid can subsequently be joined through within-grid alkene metathesis reactions to form a topologically trivial macrocycle (unknot), a doubly interlocked [2]catenane (Solomon link) and a knot with seven crossings in a 258-atom-long closed loop. This 74 knot topology corresponds to that of an endless knot, which is a basic motif of Celtic interlace, the smallest Chinese knot and one of the eight auspicious symbols of Buddhism and Hinduism. The weaving of molecular strands within a discrete layer by anion-template metal-ion coordination opens the way for the synthesis of other molecular knot topologies and to woven polymer materials.
Collapse
Affiliation(s)
- David A Leigh
- School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, China. .,Department of Chemistry, University of Manchester, Manchester, UK.
| | - Jonathan J Danon
- Department of Chemistry, University of Manchester, Manchester, UK
| | | | | | | | | |
Collapse
|
9
|
Abstract
The 18 kDa translocator protein (TSPO) is an evolutionarily conserved transmembrane protein found embedded in the outer mitochondrial membrane. A secondary target for the benzodiazepine diazepam, TSPO has been a protein of interest for researchers for decades, particularly owing to its well-established links to inflammatory conditions in the central and peripheral nervous systems. It has become a key biomarker for assessing microglial activation using positron emission tomography (PET) imaging in patients with diseases ranging from atherosclerosis to Alzheimer’s disease. This Account describes research published by our group over the past 15 years surrounding the development of TSPO ligands and their use in probing the function of this high-value target.
Collapse
|
10
|
Sokias R, Werry EL, Alison Cheng HW, Lloyd JH, Sohler G, Danon JJ, Montgomery AP, Du JJ, Gao Q, Hibbs DE, Ittner LM, Reekie TA, Kassiou M. Tricyclic heterocycles display diverse sensitivity to the A147T TSPO polymorphism. Eur J Med Chem 2020; 207:112725. [DOI: 10.1016/j.ejmech.2020.112725] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2020] [Revised: 08/02/2020] [Accepted: 08/03/2020] [Indexed: 12/11/2022]
|
11
|
Affiliation(s)
- Michael Moir
- School of Chemistry, The University of Sydney, Sydney, Australia
| | | | - Tristan A. Reekie
- Research School of Chemistry, The Australian National University, Canberra, Australia
| | - Michael Kassiou
- School of Chemistry, The University of Sydney, Sydney, Australia
| |
Collapse
|
12
|
Ryan P, Xu M, Davey AK, Danon JJ, Mellick GD, Kassiou M, Rudrawar S. O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease. ACS Chem Neurosci 2019; 10:2209-2221. [PMID: 30985105 DOI: 10.1021/acschemneuro.9b00143] [Citation(s) in RCA: 51] [Impact Index Per Article: 10.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
Abstract
Post-translational modifications (PTMs) of proteins are becoming the focus of intense research due to their implications in a broad spectrum of neurodegenerative diseases. Various PTMs have been identified to alter the toxic profiles of proteins which play critical roles in disease etiology. In Alzheimer's disease (AD), dysregulated phosphorylation is reported to promote pathogenic processing of the microtubule-associated tau protein. Among the PTMs, the enzymatic addition of N-acetyl-d-glucosamine (GlcNAc) residues to Ser/Thr residues is reported to deliver protective effects against the pathogenic processing of both amyloid precursor protein (APP) and tau. Modification of tau with as few as one single O-GlcNAc residue inhibits its toxic self-assembly. This modification also has the same effect on the assembly of the Parkinson's disease (PD) associated α-synuclein (ASyn) protein. In fact, O-GlcNAcylation ( O-linked GlcNAc modification) affects the processing of numerous proteins implicated in AD, PD, amyotrophic lateral sclerosis (ALS), and Huntington's disease (HD) in a similar manner. As such, manipulation of a protein's O-GlcNAcylation status has been proposed to offer therapeutic routes toward addressing multiple neurodegenerative pathologies. Here we review the various effects that O-GlcNAc modification, and its modulated expression, have on pathogenically significant proteins involved in neurodegenerative disease.
Collapse
Affiliation(s)
- Philip Ryan
- Menzies Health Institute Queensland, Griffith University, Gold Coast 4222, Australia
- School of Pharmacy and Pharmacology, Griffith University, Gold Coast, 4222, Australia
- Quality Use of Medicines Network, Griffith University, Gold Coast, 4222, Australia
| | - Mingming Xu
- Griffith Institute for Drug Discovery, Griffith University, Nathan, 4111, Australia
| | - Andrew K. Davey
- Menzies Health Institute Queensland, Griffith University, Gold Coast 4222, Australia
- School of Pharmacy and Pharmacology, Griffith University, Gold Coast, 4222, Australia
- Quality Use of Medicines Network, Griffith University, Gold Coast, 4222, Australia
| | | | - George D. Mellick
- Quality Use of Medicines Network, Griffith University, Gold Coast, 4222, Australia
| | - Michael Kassiou
- School of Chemistry, The University of Sydney, NSW 2006, Australia
| | - Santosh Rudrawar
- Menzies Health Institute Queensland, Griffith University, Gold Coast 4222, Australia
- School of Pharmacy and Pharmacology, Griffith University, Gold Coast, 4222, Australia
- Quality Use of Medicines Network, Griffith University, Gold Coast, 4222, Australia
- Griffith Institute for Drug Discovery, Griffith University, Nathan, 4111, Australia
- School of Chemistry, The University of Sydney, NSW 2006, Australia
| |
Collapse
|
13
|
Danon JJ, Leigh DA, Pisano S, Valero A, Vitorica‐Yrezabal IJ. A Six-Crossing Doubly Interlocked [2]Catenane with Twisted Rings, and a Molecular Granny Knot. Angew Chem Int Ed Engl 2018; 57:13833-13837. [PMID: 30152565 PMCID: PMC6221036 DOI: 10.1002/anie.201807135] [Citation(s) in RCA: 25] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2018] [Revised: 08/13/2018] [Indexed: 11/17/2022]
Abstract
A molecular 6 2 3 link (a six crossing, doubly interlocked, [2]catenane with twisted rings) and a 31 #31 granny knot (a composite knot made up of two trefoil tangles of the same handedness) were constructed by ring-closing olefin metathesis of an iron(II)-coordinated 2×2 interwoven grid. The connections were directed by pendant phenyl groups to be between proximal ligand ends on the same faces of the grid. The 6 2 3 link was separated from the topoisomeric granny knot by recycling size-exclusion chromatography. The identity of each topoisomer was determined by tandem mass spectrometry and the structure of the 6 2 3 link confirmed by X-ray crystallography, which revealed two 82-membered macrocycles, each in figure-of-eight conformations, linked through both pairs of loops.
Collapse
Affiliation(s)
- Jonathan J. Danon
- School of ChemistryUniversity of ManchesterOxford RoadManchesterM13 9PLUK
| | - David A. Leigh
- School of ChemistryUniversity of ManchesterOxford RoadManchesterM13 9PLUK
| | - Simone Pisano
- School of ChemistryUniversity of ManchesterOxford RoadManchesterM13 9PLUK
| | - Alberto Valero
- School of ChemistryUniversity of ManchesterOxford RoadManchesterM13 9PLUK
| | | |
Collapse
|
14
|
Danon JJ, Leigh DA, Pisano S, Valero A, Vitorica‐Yrezabal IJ. A Six‐Crossing Doubly Interlocked [2]Catenane with Twisted Rings, and a Molecular Granny Knot. Angew Chem Int Ed Engl 2018. [DOI: 10.1002/ange.201807135] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Affiliation(s)
- Jonathan J. Danon
- School of ChemistryUniversity of Manchester Oxford Road Manchester M13 9PL UK
| | - David A. Leigh
- School of ChemistryUniversity of Manchester Oxford Road Manchester M13 9PL UK
| | - Simone Pisano
- School of ChemistryUniversity of Manchester Oxford Road Manchester M13 9PL UK
| | - Alberto Valero
- School of ChemistryUniversity of Manchester Oxford Road Manchester M13 9PL UK
| | | |
Collapse
|
15
|
Fletcher JM, Bartlett GJ, Boyle AL, Danon JJ, Rush LE, Lupas AN, Woolfson DN. N@a and N@d: Oligomer and Partner Specification by Asparagine in Coiled-Coil Interfaces. ACS Chem Biol 2017; 12:528-538. [PMID: 28026921 DOI: 10.1021/acschembio.6b00935] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
The α-helical coiled coil is one of the best-studied protein-protein interaction motifs. As a result, sequence-to-structure relationships are available for the prediction of natural coiled-coil sequences and the de novo design of new ones. However, coiled coils adopt a wide range of oligomeric states and topologies, and our understanding of the specification of these and the discrimination between them remains incomplete. Gaps in our knowledge assume more importance as coiled coils are used increasingly to construct biomimetic systems of higher complexity; for this, coiled-coil components need to be robust, orthogonal, and transferable between contexts. Here, we explore how the polar side chain asparagine (Asn, N) is tolerated within otherwise hydrophobic helix-helix interfaces of coiled coils. The long-held view is that Asn placed at certain sites of the coiled-coil sequence repeat selects one oligomer state over others, which is rationalized by the ability of the side chain to make hydrogen bonds, or interactions with chelated ions within the coiled-coil interior of the favored state. We test this with experiments on de novo peptide sequences traditionally considered as directing parallel dimers and trimers, and more widely through bioinformatics analysis of natural coiled-coil sequences and structures. We find that when located centrally, rather than near the termini of such coiled-coil sequences, Asn does exert the anticipated oligomer-specifying influence. However, outside of these bounds, Asn is observed less frequently in the natural sequences, and the synthetic peptides are hyperthermostable and lose oligomer-state specificity. These findings highlight that not all regions of coiled-coil repeat sequences are equivalent, and that care is needed when designing coiled-coil interfaces.
Collapse
Affiliation(s)
- Jordan M. Fletcher
- School
of Chemistry, University of Bristol, Cantock’s Close, Bristol BS8 1TS, United Kingdom
| | - Gail J. Bartlett
- School
of Chemistry, University of Bristol, Cantock’s Close, Bristol BS8 1TS, United Kingdom
| | - Aimee L. Boyle
- School
of Chemistry, University of Bristol, Cantock’s Close, Bristol BS8 1TS, United Kingdom
| | - Jonathan J. Danon
- School
of Chemistry, University of Bristol, Cantock’s Close, Bristol BS8 1TS, United Kingdom
| | - Laura E. Rush
- School
of Chemistry, University of Bristol, Cantock’s Close, Bristol BS8 1TS, United Kingdom
| | - Andrei N. Lupas
- Department
of Protein Evolution, Max Planck Institute for Developmental Biology, 72076 Tübingen, Germany
| | - Derek N. Woolfson
- School
of Chemistry, University of Bristol, Cantock’s Close, Bristol BS8 1TS, United Kingdom
- School
of Biochemistry, University of Bristol, Medical Sciences Building, University
Walk, Bristol BS8 1TD, United Kingdom
- BrisSynBio, University of Bristol, Life Science
Building, Tyndall Avenue, Bristol BS8 1TQ, United Kingdom
| |
Collapse
|
16
|
Danon JJ, Krüger A, Leigh DA, Lemonnier JF, Stephens AJ, Vitorica-Yrezabal IJ, Woltering SL. Braiding a molecular knot with eight crossings. Science 2017; 355:159-162. [DOI: 10.1126/science.aal1619] [Citation(s) in RCA: 180] [Impact Index Per Article: 25.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2016] [Accepted: 12/13/2016] [Indexed: 01/16/2023]
|
17
|
Abstract
[4]Rotaxanes featuring three axles threaded through a single ring have been prepared through active metal template synthesis. Nickel-catalyzed sp(3)-sp(3) homocouplings of alkyl bromide "half-threads" through 37- and 38-membered 2,2':6',2″-terpyridyl macrocycles generate triply threaded [4]rotaxanes in up to 11% yield. An analogous 39-membered macrocycle produced no rotaxane products under similar conditions. The constitutions of the [4]rotaxanes were determined by NMR spectroscopy and mass spectrometry. Doubly threaded [3]rotaxanes were also obtained from the reactions but no [2]rotaxanes were isolated, suggesting that upon demetalation the axle of a singly threaded rotaxane can slip through a macrocycle that is sufficiently large to accommodate three threads.
Collapse
Affiliation(s)
- Jonathan J Danon
- School of Chemistry, University of Manchester , Oxford Road, Manchester M13 9PL, United Kingdom
| | - David A Leigh
- School of Chemistry, University of Manchester , Oxford Road, Manchester M13 9PL, United Kingdom.,School of Chemistry, University of Edinburgh , The King's Buildings, West Mains Road, Edinburgh EH9 3JJ, United Kingdom
| | - Paul R McGonigal
- School of Chemistry, University of Edinburgh , The King's Buildings, West Mains Road, Edinburgh EH9 3JJ, United Kingdom
| | - John W Ward
- School of Chemistry, University of Manchester , Oxford Road, Manchester M13 9PL, United Kingdom
| | - Jhenyi Wu
- School of Chemistry, University of Edinburgh , The King's Buildings, West Mains Road, Edinburgh EH9 3JJ, United Kingdom
| |
Collapse
|
18
|
Abstract
A molecular Solomon link was synthesized through the assembly of an interwoven molecular grid consisting of four bis(benzimidazolepyridyl)benzthiazolo[5,4-d]thiazole ligands and four zinc(II), iron(II), or cobalt(II) cations, followed by ring-closing olefin metathesis. NMR spectroscopy, mass spectrometry, and X-ray crystallography confirmed the doubly interlocked topology, and subsequent demetalation afforded the wholly organic Solomon link. The synthesis, in which each metal ion defines the crossing point of two ligand strands, suggests that interwoven molecular grids should be useful scaffolds for the rational construction of other topologically complex structures.
Collapse
Affiliation(s)
- Jonathon E Beves
- School of Chemistry, University of Edinburgh, The King's Buildings, West Mains Road, Edinburgh, EH9 3JJ (UK)
| | - Jonathan J Danon
- School of Chemistry, University of Manchester, Oxford Road, Manchester, M13 9PL (UK) http://www.catenane.net
| | - David A Leigh
- School of Chemistry, University of Edinburgh, The King's Buildings, West Mains Road, Edinburgh, EH9 3JJ (UK).
- School of Chemistry, University of Manchester, Oxford Road, Manchester, M13 9PL (UK) http://www.catenane.net.
| | - Jean-François Lemonnier
- School of Chemistry, University of Manchester, Oxford Road, Manchester, M13 9PL (UK) http://www.catenane.net
| | - Iñigo J Vitorica-Yrezabal
- School of Chemistry, University of Manchester, Oxford Road, Manchester, M13 9PL (UK) http://www.catenane.net
| |
Collapse
|
19
|
Beves JE, Danon JJ, Leigh DA, Lemonnier JF, Vitorica-Yrezabal IJ. Inside Back Cover: A Solomon Link through an Interwoven Molecular Grid (Angew. Chem. Int. Ed. 26/2015). Angew Chem Int Ed Engl 2015. [DOI: 10.1002/anie.201504557] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
20
|
Beves JE, Danon JJ, Leigh DA, Lemonnier JF, Vitorica-Yrezabal IJ. Innenrücktitelbild: A Solomon Link through an Interwoven Molecular Grid (Angew. Chem. 26/2015). Angew Chem Int Ed Engl 2015. [DOI: 10.1002/ange.201504557] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
21
|
|